Access provided by Autonomous University of Puebla. Download reference work entry PDF
Keywords
- Atopic Dermatitis
- Herpes Zoster
- Severe Combine Immunodeficiency
- Seborrheic Dermatitis
- Molluscum Contagiosum
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Definition
Atopic dermatitis or infantile eczema is a skin inflammation characterized by intense pruritus and scratching, which result in skin damage. The skin lesions manifest in the form of papulation, excoriation, oozing, crusting, and secondary infection. The severity and intensity of symptoms vary from one patient to another. The hallmark of atopic dermatitis (AD) is itching. The skin changes that follow are due to traumatization of the skin by persistent scratching. The symptoms are made worse by increased heat, perspiration, excessive dryness, irritation, psychological tension, and secondary infections.
Epidemiology
Although AD is a common allergic disease of infancy and childhood, its exact incidence is not known. But the incidence seems to be increasing. There are no racial or geographical differences and girls may be slightly more affected. It may affect 5–20% of children, but some studies estimate the incidence to be between 1% and 4%, depending on the population studied and the methodology of the study. The higher figures are in urban population. Most infants develop AD below the age of 1 in 60% of cases and by the age of 5 in another 30%. It is unusual for an infant below 2 months of age to develop AD. The occurrence of AD is much higher in families with a history of allergy. About 75% of infants and children with AD either have another allergy or have a strong family history of atopy.
Pathogenesis and Genetics
The pathogenesis of AD is more complex than it was previously thought. This includes impaired epidermal barrier function, immune disorders in which T-cells, Langerhans cells, and immune effector cells induce inflammatory response to various environmental factors such as irritants, infections, chemicals, and allergens. The integrity of the epidermis is important for a healthy skin. This integrity is kept by the interaction of keratinocytes and a variety of proteins such as Filaggrin, enzymes, and lipids. Disruption of this barrier allows foreign antigen to penetrate and come in contact with immune cells and release proinflammatory agents that lead to the clinical and pathological manifestations of AD. Atopic skin keratinocytes are defective in binding water, which is important for a healthy epidermal barrier. This dryness leads to pruritus with scratching, skin trauma, and inflammation. Several genetic factors involved in the epidermal permeability barrier defect have been described. These include Filaggrin mutation that leads to icthyosin (R 501X and 2282dL4), and defective Spink5 that leads to cleavage of intercellular attachments, and hence, the corneocyte cohesion, which weakens the skin barrier function. The defects open the way for foreign antigens to enter through the epidermis and interact with immune cells, leading to sensitization and inflammation. AD is a genetic disease based on twin studies and family history. The trait is more often inherited through a maternal gene rather than a paternal one. Many patients have Filaggrin mutations.
Clinical Manifestations
Clinical features of atopic dermatitis depend on the severity and chronicity of inflammation. The most prominent feature of atopic dermatitis is itching. The skin is usually dry or erythematous with some degree of lichenification, or oozing, crusting, and acutely inflamed, depending on the stage of inflammation. Skin manifestations go through different stages, depending on the chronicity of symptoms and the age of the patient. Classification of atopic dermatitis in relation to age is divided into three groups:
-
1.
Infantile – from 2 months to 2 years
-
2.
Childhood – from 2 to 10 years
-
3.
Adolescent – from 11 to 20 years
In infants, the early feature is dry erythema on the cheeks, which may become oozy with crust formation and secondary infection. The eczema may spread to involve the forehead, scalp, and postauricular areas. It may also involve the extensor surfaces of the upper and lower extremities and may become generalized. The baby is usually irritable and scratches the skin constantly. The baby may look unhappy due to severe itching, which may interfere with feeding and sleep. This stage has a tendency to improve as infants grow older. Once an infant starts crawling, the skin’s dryness increases and the papules tend to become larger, confluent, and crusty. In older children, the skin lesions have a tendency to involve the flexural areas, with the antecubital and popliteal fossae and the back of the neck being the preferred areas. Skin infection may complicate the picture further and leads to confusion in diagnosis. In chronic severe eczema, the skin of the eyelids becomes thickened and forms transverse lines known as Dennie–Morgan lines.
Complications
Complications of atopic dermatitis in both infants and children include
-
1.
Secondary infections with Staphylococcus aureus, herpes simplex, herpes zoster (eczema herpeticum), and molluscum contagiosum. Herpes simplex may become disseminated, causing serious consequences.
-
2.
Subcapsular cataract occurs in about 16%.
-
3.
Keratoconus and ulceration of the cornea.
-
4.
In cases of severe generalized eczema, psychological complications may lead to withdrawal of the child from social activities.
Differential Diagnosis
Seborrheic dermatitis is easy to differentiate; it usually starts as cradle cap with thick, greasy, yellowish scales. It begins before the age of 2 months and causes minimal or no itching. In comparison, atopic dermatitis starts after the age of 2 months with intense itching. Classic seborrheic dermatitis follows the hairline with slight erythema, while atopic dermatitis is inflamed mostly at the center, and when scales are present, they are usually dry. In addition, the smell of seborrheic dermatitis (mouse-like) is characteristic.
Contact dermatitis is rather uncommon in infants and children. The common causes are earrings, wristwatches, and metal buttons in trousers. The site of dermatitis correlates with the size and site of the causative metal.
Primary immunodeficiency syndromes include Wiskott–Aldrich syndrome, which is characterized by eczema, immunodeficiency, thrombocytopenia, and bleeding early in infancy. It is X-linked, and there is usually a history of similar cases in the family. Severe combined immunodeficiency (SCID) is very easy to differentiate from atopic dermatitis. The history of severe infections with low virulence and uncommon organisms makes the diagnosis easy. The dermatitis in SCID is due to graft-versus-host disease, and pruritus is unusual. Hyper-IgE syndrome (Job syndrome) is very easily confused with atopic dermatitis. In hyper-IgE syndrome, the level of serum IgE is extremely high, and the infant has a history of deep-seated infections, including sinusitis and skin and pulmonary abscesses. The distribution of the eczematoid eruption in hyper-IgE syndrome is different from that of severe atopic dermatitis. The first involves the entire skin from head to toe, and patients have coarse facial features. The color of the eczema ranges from coppery red to violaceous red, with distribution mostly on the extensor surfaces. Table 133.1 summarizes the most important differential points between atopic dermatitis and other conditions.
Diagnosis
History and physical examination are usually enough to make the diagnosis of atopic dermatitis. The minimal criteria to establish the diagnosis should include the followings: chronic or recurrent dermatitis with itching, characteristic distribution in relation to age, and white dermographism. The history should include detailed questioning regarding the age of onset, severity of symptoms, and manifestations of other allergic diseases, both in the patient and relatives. Evolution of the skin eruption, the presence of pruritus, and the effect of seasonal variations are pertinent questions in history taking. Triggers such as foods, clothes, drugs, and changes in weather should be inquired into. If food is suspected to be a trigger for the patient’s symptoms, confirmation by oral challenge and appropriate tests, performed by a physician experienced in the field of allergy, should be sought. Frequency of bathing and showers are important to know, because of their drying effect on the skin. By physical examination, the patient may have a classic appearance and distribution of atopic dermatitis; in addition, other stigmata of allergy may be present.
Diagnostic procedures include skin prick test. Allergens should include inhalants and common foods consumed by the patient. All positive tests should be confirmed by elimination and oral challenge. Other diagnostic tests include complete blood count, serum IgE level, and culture from surfaces of the infected skin. If the child has extensive skin involvement, skin testing may not be possible. In this case, a radio allergo sorbent tes (RAST) for the common foods and inhalants allergens is an alternative diagnostic tool. Although the majority of infants and children with atopic dermatitis react to foods, the results should not be taken as cause and effect unless confirmed by elimination and challenge.
Management
Patients with atopic dermatitis live in a vicious cycle of scratching and skin inflammation, which aggravate each other. Therefore, the management of atopic dermatitis should attack two points in this vicious cycle: (1) stopping the itching and (2) healing the inflamed skin.
General Management
Excessive dryness, perspiration, and overheating should be avoided as much as possible. Rough fabrics in clothing should be avoided and soft fabrics made of cotton or silk should replace them. Nails should always be kept trimmed to minimize trauma to the skin from scratching.
To bathe or not to bathe? It is a known fact that frequent bathing with soap and water increases skin dryness and, hence, pruritus and scratching of the skin. The traditional teaching to the patient is not to bathe or at least to minimize bathing and showers to once a week. From a practical point of view, it is extremely difficult for the patient and family to accept this recommendation due to hygienic reasons. Therefore, the recommendations in this regard should take into account the social habits and living conditions of the patient and the family. The parents should follow their usual practice of bathing their child as long as they apply moisturizing creams and lotions immediately after the bath or shower. Soap that has a high content of fat is preferred, and it is also preferable not to use scented or perfumed soap. The parents should be encouraged to use creams and lotions of their choice as liberally and as often as they desire.
Antipruritic Medications
Any of the following antihistamines can be used to relieve itching. cyproheptadine (Periactin) in a dose of 2 mg every 6–8 h, or hydroxyzine 5 mg every 6 h, can be used in infants younger than 6 months. The dose can be increased to 10 mg every 6 h in older children. The latter drug is tolerated very well, and the dose can be increased by 6 mg every 5–7 days. Because itching is worse at night, it is advisable to double the dosage at bedtime. If hydroxyzine is not enough to relieve the symptoms, diphenhydramine (Benadryl) in a dose of 0.5–1 mg/kg (maximum 25 mg) every 6 h can be added. The treatment with antihistamines should be given on a continuous basis rather than intermittently. Relieving the itch will help the skin to heal faster, and therefore the need for anti-inflammatory drugs will decrease.
Control of Infection
If there is evidence of skin infection, antibiotics that are active against S. aureus should be used. Topical antibiotics should be completely avoided in patients with dermatitis. Patients with a history of frequent skin infections may benefit from prophylaxis with long-term antibiotics active against S. aureus. Erythromycin is an alternative drug when the patient is allergic to penicillins.
Dietary Manipulation
Dietary restriction should be reserved for those infants who have definite evidence of allergy to food. If there is evidence of coexistence of respiratory allergy, such as allergic rhinoconjunctivitis and/or bronchial asthma, and the allergen cannot be avoided, immunotherapy guided by history and skin tests may be added to the treatment.
Local Treatment
In the acute weeping phase, topical application of a wet dressing should be used at least four times a day on the oozing areas. Burow’s solution is aluminum acetate 1:40 and can be prepared by dissolving Domeboro in 500 mL of tap water. A clean gauze is then soaked in the solution and applied to the oozing area. Once the skin becomes relatively dry and less inflamed, with no oozing, corticosteroid creams can be applied once to twice a day. In cases where the skin is thick and lichenified with no signs of infection, corticosteroid ointment can be applied but avoid skin folds and facial areas. Extremely thick eczematous areas on the extremities need an occlusive dressing with steroid ointment. In very severe cases, systemic, short-acting corticosteroid administration may become necessary for the control of inflammation. Ultraviolet light (PUVA) or cyclosporin A may be used in extremely resistant generalized dermatitis.
In some patients with atopic dermatitis, hypopigmented or discolored areas appear after healing and may be of concern to them. In these cases, reassurance is all that is needed, because the skin color will go back to normal in due time. Topical potent fluorinated corticosteroids should never be applied to facial areas, especially around the eyes. The preferred corticosteroid is 0.5–1% hydrocortisone cream applied twice to three times a day for facial dermatitis. Topical calcineurin inhibitors such as tacrolimus and pimecrolimus applied twice daily have been introduced recently. In very severe cases, oral cyclosporine A may be used with caution.
Prognosis and Prevention
Although prognosis depends on the severity and extent of skin involvement, at least 50% of infants with atopic dermatitis become asymptomatic as they grow older. If there is a positive family history of allergy, atopic dermatitis in early infancy is an indication that other forms of allergy will follow. This knowledge is useful to the treating physician and the family in planning treatment and prophylaxis. Approximately 70% of infants and children who start with atopic dermatitis and have a positive family history of atopy end up with bronchial asthma and allergic rhinitis. If the cord blood IgE level of an infant is greater than 1 U/mL along with a positive family history, the chances of development of atopic dermatitis and other allergies in that infant are extremely high. Mothers of such infants should be advised to breast-feed their babies and to be cautious in introducing solid foods or cow’s milk formula into their infant’s diet before the age of 6 months. Mothers should also avoid potentially allergenic foods such as milk, eggs, peanuts, and fish in their diet while nursing their infants.
References
Akdis CA, Akdis M, Bieber T et al (2006) Diagnosis and treatment of atopic dermatis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immonol 118:152
Bath-Hextall F, Delamere F, Williams H (2008) Dietary exclusions for established atopic eczema. Cockrone Database Syst Rev CP005203
Baurecht H, Irvine AD, Novak N et al (2007) Toward a major risk factor for atopic eczema: meta-nalysis of filaggrin polymorphism data. J Allergy Clin Immunol 120:1406
Birnie AJ, Bath-Hextall FJ, Ravenscroft JC, Williams HC (2008) Interventions to reduce Staphylococcus aureus in the management of atopic eczema. Cochrane Database Syst Rev, doi: 10.1002/14651858.CD003871
Chan LS (2008) Atopic dermatitis. Current Dir Autoimmune 10:76
Cork MJ, Robinson DA, Vasilopoulos Y et al (2006) New perspective on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 118:3
de Prost Y (1992) Atopic dermatitis: recent therapeutic advances. Padiatr Dermatol 9:386
Eigenmann PA, Sicherer SH, Borkowski TA et al (1998) Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 101:8
Elias PM, Steinhoff M (2008) “Outside-to-inside” (and now back to “outside”) pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 128:1007
Ellis C, Lugar T, Abeck D et al (2003) International consensus conference on atopic dermatitis II: clinical update and current treatment strategies. Br J Dermatol 148(S63):3
Grimaet R, Mengeaud V, Cambazord F (2001) The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: A randomized controlled study. Dermatology 214:61
Gupta J, Grube E, Erickson MB et al (2008) intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. J Allergy Clin Immunol 121:725
Hoare C, Wan L, PoA WH (2000) Systematic review of treatments for atopic eczema. Health Technol Assess 4:1
Jones SM, Ha S (1993) The role of allergens in atopic dermatitis. Clin Rev Allergy 11:471
Kemper’s S, Boguniewicz M, Carter E et al (2004) A-rondomized investigator – blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis. J Am Acad Dermatol 52:810
Klein PA, Clark RA (1999) An evidence-based review of the efficancy of anti-histamines in relieving pruritus in atopic dermatitis. Arch Dermatol 135:1522
Klein GL, Galant SP (1980) A comparison of the antipruritic efficacy of hydroxyzine and cyproheptadine in children with atopic dermatitis. Ann Allergy 44:142
Langan SM, Bourke JF, Silcocks P, Williams HC (2006) An exploratory prospective observational study of environmental factors exacerbating atopic eczema in children. Br J Dermatol 154:979
Larsen FS, Holm NV, Henningsen K (1986) Atopic dermatitis. A genetic-epidemiologic Study is a population-based twin sample. J Am Acad Dermatol 15:487
Loden M (2003) The skin barrier and use of moisturizers in atopic dermatitis. Clin Dermatol 21:145
Mc Grath JA, Vitto J (2008) The filaggrin story: novel insights into skin-barrier function and disease. Trends Mol Med 14:20
Mc Henry PM, Williams HC, Bingham EA et al (1995) Management of atopic eczema. BMJ 310:843–847
Meduri NB, Vander Griff T, Rasmussen H, Jacobe H (2007) Phototherapy in the management of atopic dermatitis: a systematic review. Photodermatol Photoimmunol Photomed 23:106
Reitamo S, Van Leent EJ, Ho V et al (2002) Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 109:539
Ruiz RG, Kemeny DM, Price JF (1992) Higher risk of infantile atopic dermatitis from maternal atopy. Clin Exp Allergy 22:762
Sampson HA, Scanlon SM (1989) Natural history of food hypersensitivity in children with atopic dermatitis. J Pediatr 115:23–27
Spergel JM, Paller AS (2003) Atopic dermatitis and the atopic march. J Allergy Clin Immunol 112:S118
Williams HC, Strachan DP (1998) The natural history of childhood eczema: observations from the British 1958 cohort study. Br J Dermatol 139:834
Williams H, Robertson C, Stewart A et al (1999) Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol 103:125
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Harfi, H.A. (2012). Atopic Dermatitis. In: Elzouki, A.Y., Harfi, H.A., Nazer, H.M., Stapleton, F.B., Oh, W., Whitley, R.J. (eds) Textbook of Clinical Pediatrics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02202-9_133
Download citation
DOI: https://doi.org/10.1007/978-3-642-02202-9_133
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-02201-2
Online ISBN: 978-3-642-02202-9
eBook Packages: MedicineReference Module Medicine